These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1150 related items for PubMed ID: 25742499

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3.
    Wang C, Liu P, Wu H, Cui P, Li Y, Liu Y, Liu Z, Gou S.
    Oncotarget; 2016 Mar 22; 7(12):14912-24. PubMed ID: 26908446
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. MiR-10b inhibits migration and invasion of pancreatic ductal adenocarcinoma via regulating E2F7.
    Xu C, Qi X.
    J Clin Lab Anal; 2020 Oct 22; 34(10):e23442. PubMed ID: 32592206
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. MiR-708-5p inhibits the progression of pancreatic ductal adenocarcinoma by targeting Sirt3.
    Huang S, Guo H, Cao Y, Xiong J.
    Pathol Res Pract; 2019 Apr 22; 215(4):794-800. PubMed ID: 30683474
    [Abstract] [Full Text] [Related]

  • 10. MicroRNA-301a-3p promotes pancreatic cancer progression via negative regulation of SMAD4.
    Xia X, Zhang K, Cen G, Jiang T, Cao J, Huang K, Huang C, Zhao Q, Qiu Z.
    Oncotarget; 2015 Aug 28; 6(25):21046-63. PubMed ID: 26019136
    [Abstract] [Full Text] [Related]

  • 11. Enhancer of zeste homolog 2 silences microRNA-218 in human pancreatic ductal adenocarcinoma cells by inducing formation of heterochromatin.
    Li CH, To KF, Tong JH, Xiao Z, Xia T, Lai PB, Chow SC, Zhu YX, Chan SL, Marquez VE, Chen Y.
    Gastroenterology; 2013 May 28; 144(5):1086-1097.e9. PubMed ID: 23395645
    [Abstract] [Full Text] [Related]

  • 12. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
    Li DD, Fu ZQ, Lin Q, Zhou Y, Zhou QB, Li ZH, Tan LP, Chen RF, Liu YM.
    World J Gastroenterol; 2015 Aug 21; 21(31):9348-57. PubMed ID: 26309360
    [Abstract] [Full Text] [Related]

  • 13. miR-367 promotes epithelial-to-mesenchymal transition and invasion of pancreatic ductal adenocarcinoma cells by targeting the Smad7-TGF-β signalling pathway.
    Zhu Z, Xu Y, Zhao J, Liu Q, Feng W, Fan J, Wang P.
    Br J Cancer; 2015 Apr 14; 112(8):1367-75. PubMed ID: 25867271
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. miR-545 inhibited pancreatic ductal adenocarcinoma growth by targeting RIG-I.
    Song B, Ji W, Guo S, Liu A, Jing W, Shao C, Li G, Jin G.
    FEBS Lett; 2014 Nov 28; 588(23):4375-81. PubMed ID: 25315416
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Expression of microRNA-218 in human pancreatic ductal adenocarcinoma and its correlation with tumor progression and patient survival.
    Zhu Z, Xu Y, Du J, Tan J, Jiao H.
    J Surg Oncol; 2014 Feb 28; 109(2):89-94. PubMed ID: 24166773
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 58.